Elevance Health Inc.

ELV Healthcare Medical - Healthcare Plans NYSE

Back to Search

$285.17

$-1.31 (-0.46%)

Open: $286.50 | High: $289.42 | Low: $281.50 | Prev Close: $286.48

Market Cap: $62.94B

Volume: 1.0M | Avg: 1.8M

Last updated: March 06, 2026 at 06:02 PM
Investment Rating
A-

Buy

Overall Score: 80/100

Rating Breakdown:
DCF Score 5/5
100%
Strong Buy
ROE Score 4/5
80%
Buy
ROA Score 4/5
80%
Buy
D/E Score 1/5
20%
Strong Sell
P/E Score 3/5
60%
Neutral
P/B Score 3/5
60%
Neutral
Add to Watchlist Add to Portfolio
Stock Score Analysis
E

Stock Score: 492

Comprehensive Quality Assessment

Component Breakdown:
Efficiency 30
Financial Health 40
Growth 20
Market Sentiment 20
Risk 40
Lower is better
Valuation 42
Momentum 0
View Full Stock Score Dashboard
Valuation Metrics
Valuation Ratios
P/E Ratio 11.31
P/B Ratio 1.44
P/S Ratio 0.32
EPS $25.21
Beta 0.47
Shares Outstanding 220.71M
Price Range & Moving Averages
52-Week High $458.75
52-Week Low $273.71
SMA 50 $345.10
SMA 200 $337.29
Dividend Information
Dividend Yield 2.40%
Annual Dividend $6.84
Earnings
Next Earnings April 21, 2026 01:30 PM ET
Financial Ratios
Margins
Gross Margin 25.6%
Operating Margin 4.1%
Net Margin 2.8%
Returns
ROE 13.0%
ROA 4.7%
Liquidity & Leverage
Debt/Equity 0.76
Current Ratio 1.24
Quick Ratio 1.24
Balance Sheet
Total Assets $121.49B
Total Liabilities $77.47B
Total Equity $43.88B
Cash $9.49B
Total Debt $33.23B
Net Debt $23.74B
Income Statement
Revenue $199.12B
Gross Profit $50.90B
Operating Income $8.11B
Net Income $5.66B
EBITDA $9.66B
Revenue/Share $897.77
Cash Flow
Operating CF $4.29B
CapEx $1.12B
Free Cash Flow $3.17B
Book Value/Share $198.49
Tangible Book/Share $20.21
Equity/Share $197.84
Technical Indicators
RSI (14) 20.00 Oversold
MACD
-15.70 Signal: -10.79
Volatility 48.84%
Trading Signal Oversold
Performance & Returns
Total Returns
1 Year -29.38%
Risk-Adjusted Returns
Sharpe Ratio -1.12 Poor
Volatility (Ann.) 39.18% Moderate
vs S&P 500 (SPY)
ELV (1Y) -29.38%
S&P 500 (1Y) +13.03%
Alpha (Excess Return) -42.41%
Risk-free rate: 4.5% (3-month US Treasury) • Based on 199 trading days
Sector Comparison (Healthcare)
Compared to 52 peers in Healthcare
Metric ELV Sector Avg Percentile
P/E Ratio 11.31 27.97 11%
P/B Ratio 1.44 -19.55 21%
ROE (%) 13.01% -9.54% 53%
Net Margin (%) 2.84% 9.44% 23%
Stock Score 492 544.0 19%
1Y Return (%) -29.38 % +8.88 % 8%
Percentile: 0% = worst in sector, 100% = best in sector
📊 Historical Price Analysis (Last 200 Days)

Loading chart...

Technical Analysis
Ticker Close SMA 5 SMA 8 SMA 13 SMA 50 SMA 200 RSI (14) MACD Volatility (%) Volume Signal SMA Decision
ELV $285.17 $288.54 $301.93 $316.42 $344.02 $336.73 20.00 -15.70 48.84% 1031681 Strong Short Bearish Stack
Candlestick Patterns

There wasn't any recognizable pattern for the ELV stock

News Sentiment
📊 Ticker 📰 Headline 💭 Sentiment 📡 Source 🔗 URL
ELV INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Elevance Health, Inc. - ELV Neutral prnewswire.com Read More
ELV Elevance Health, Inc. (ELV) Presents at Barclays 28th Annual Global Healthcare Conference Transcript Neutral seekingalpha.com Read More
ELV Market Today: Oil Swings, Oracle Pops; Meta Buys Bot Network Neutral gurufocus.com Read More
ELV INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Elevance Health, Inc. - ELV Neutral globenewswire.com Read More
ELV DKRT Investments Corp. Increases Stake in Elevance Health, Inc. $ELV Positive defenseworld.net Read More
Recent Insider Trading

No recent insider trading data available for ELV

Company Information

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

CEO Gail Koziara Boudreaux
Employees 104200
Country US
IPO Date 2001-10-30
Exchange NYSE
Website https://www.elevancehealth.com
Sector Healthcare
Industry Medical - Healthcare Plans
Similar Stocks (Healthcare - Medical - Healthcare Plans)
UNH

UnitedHealth Group Incorporated

Price: $284.50
Change: -1.48%
Market Cap: $2577B
P/E: 21.52
Score: E (445)
View Details
CVS

CVS Health Corporation

Price: $77.92
Change: -0.98%
Market Cap: $9913B
P/E: 56.06
Score: E (437)
View Details
CI

Cigna Corporation

Price: $271.63
Change: -3.43%
Market Cap: $7255B
P/E: 12.68
Score: D (540)
View Details
HUM

Humana Inc.

Price: $179.15
Change: -0.89%
Market Cap: $2160B
P/E: 18.37
Score: E (450)
View Details
Rating Metrics Explained
DCF Score (Discounted Cash Flow)

Measures the intrinsic value of the stock based on projected future cash flows. A higher score indicates the stock is undervalued relative to its DCF valuation.

ROE Score (Return on Equity)

Evaluates how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better profitability and management effectiveness.

ROA Score (Return on Assets)

Measures how efficiently a company uses its assets to generate profit. A higher ROA means better asset utilization and operational efficiency.

D/E Score (Debt-to-Equity)

Assesses the company's financial leverage and risk. Lower debt-to-equity ratios indicate less financial risk and better balance sheet health.

P/E Score (Price-to-Earnings)

Compares stock price to earnings per share. A lower P/E ratio may indicate the stock is undervalued, while a higher ratio could suggest overvaluation or growth expectations.

P/B Score (Price-to-Book)

Compares market price to book value per share. Lower P/B ratios may indicate undervaluation relative to the company's net asset value.

Rating Recommendations:

Each metric is scored on a scale of 1-5, where the scores are determined by comparing the company's performance against industry benchmarks and historical data:

  • Strong Buy (5/5): Excellent score - strong positive indicator
    • The metric significantly outperforms industry averages (top 20% of companies)
    • Indicates exceptional financial health or attractive valuation in that category
  • Buy (4/5): Good score - positive indicator
    • Above-average performance (top 40% of companies)
    • Shows strong fundamentals with room for improvement
  • Neutral (3/5): Average score - neutral indicator
    • Performance in line with industry median (middle 20%)
    • Neither significantly positive nor negative signal
  • Sell (2/5): Below average - negative indicator
    • Below-average performance (bottom 40% of companies)
    • Suggests weakness in this particular metric
  • Strong Sell (1/5): Poor score - strong negative indicator
    • Significantly underperforms industry (bottom 20%)
    • Indicates potential risk or overvaluation in that category
Note: The overall rating combines all six component scores to provide a comprehensive investment assessment. No single metric should be used in isolation for investment decisions.